138 related articles for article (PubMed ID: 11577347)
21. Can we apply the TH1-TH2 paradigm to all lymphocytes?
Colonna M
Nat Immunol; 2001 Oct; 2(10):899-900. PubMed ID: 11577341
[No Abstract] [Full Text] [Related]
22. Down-regulation of IL-18 receptor in cancer patients: its clinical significance.
Kobashi K; Iwagaki H; Yoshino T; Morimoto Y; Kohka H; Kodama M; Nishibori M; Akagi T; Tanaka N
Anticancer Res; 2001; 21(5):3285-93. PubMed ID: 11848485
[TBL] [Abstract][Full Text] [Related]
23. G-CSF-mobilized CD34+ cells cultured in interleukin-2 and stem cell factor generate a phenotypically novel monocyte.
Sconocchia G; Fujiwara H; Rezvani K; Keyvanfar K; El Ouriaghli F; Grube M; Melenhorst J; Hensel N; Barrett AJ
J Leukoc Biol; 2004 Dec; 76(6):1214-9. PubMed ID: 15345723
[TBL] [Abstract][Full Text] [Related]
24. Commensal oral bacteria antigens prime human dendritic cells to induce Th1, Th2 or Treg differentiation.
Kopitar AN; Ihan Hren N; Ihan A
Oral Microbiol Immunol; 2006 Feb; 21(1):1-5. PubMed ID: 16390334
[TBL] [Abstract][Full Text] [Related]
25. Adoptive transfer of ex vivo immune-programmed NKT lymphocytes alleviates immune-mediated colitis.
Shibolet O; Kalish Y; Klein A; Alper R; Zolotarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
J Leukoc Biol; 2004 Jan; 75(1):76-86. PubMed ID: 14557387
[TBL] [Abstract][Full Text] [Related]
26. Human T helper (Th) cell lineage commitment is not directly linked to the secretion of IFN-gamma or IL-4: characterization of Th cells isolated by FACS based on IFN-gamma and IL-4 secretion.
Cao W; Chen Y; Alkan S; Subramaniam A; Long F; Liu H; Diao R; Delohery T; McCormick J; Chen R; Ni D; Wright PS; Zhang X; Busch S; Zilberstein A
Eur J Immunol; 2005 Sep; 35(9):2709-17. PubMed ID: 16106470
[TBL] [Abstract][Full Text] [Related]
27. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin.
Batoni G; Esin S; Favilli F; Pardini M; Bottai D; Maisetta G; Florio W; Campa M
Scand J Immunol; 2005 Dec; 62(6):498-506. PubMed ID: 16316416
[TBL] [Abstract][Full Text] [Related]
28. Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-) and CD8(+) T cells in systemic lupus erythematosus.
Amel-Kashipaz MR; Huggins ML; Lanyon P; Robins A; Todd I; Powell RJ
J Autoimmun; 2001 Sep; 17(2):155-63. PubMed ID: 11591124
[TBL] [Abstract][Full Text] [Related]
29. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
[TBL] [Abstract][Full Text] [Related]
30. Constitutive expression of CIITA directs CD4 T cells to produce Th2 cytokines in the thymus.
Patel DR; Li W; Park JS; Sofi MH; Gourley TS; Hangoc G; Kaplan MH; Chang CH
Cell Immunol; 2005 Jan; 233(1):30-40. PubMed ID: 15876426
[TBL] [Abstract][Full Text] [Related]
31. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
[TBL] [Abstract][Full Text] [Related]
32. Peripheral immature CD2-/low T cell development from type 2 to type 1 cytokine production.
Loza MJ; Perussia B
J Immunol; 2002 Sep; 169(6):3061-8. PubMed ID: 12218122
[TBL] [Abstract][Full Text] [Related]
33. Natural killer cell subsets: maturation, differentiation and regulation.
Bonavida B; Lebow LT; Jewett A
Nat Immun; 1993; 12(4-5):194-208. PubMed ID: 8257826
[TBL] [Abstract][Full Text] [Related]
34. Expression of type 1 (interferon gamma) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cells.
Loza MJ; Zamai L; Azzoni L; Rosati E; Perussia B
Blood; 2002 Feb; 99(4):1273-81. PubMed ID: 11830476
[TBL] [Abstract][Full Text] [Related]
35. Distinction between IL-13+ and IFN-gamma+ natural killer cells and regulation of their pool size by IL-4.
Loza MJ; Peters SP; Zangrilli JG; Perussia B
Eur J Immunol; 2002 Feb; 32(2):413-23. PubMed ID: 11813160
[TBL] [Abstract][Full Text] [Related]
36. [Differentiation of natural killer cells into two functional subsets: NKh1 and NKh2].
Liang SJ; Xu T; Wei HM; Zhang C; Fang J; Sun R; Tian ZG
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Apr; 23(2):132-6. PubMed ID: 12905888
[TBL] [Abstract][Full Text] [Related]
37. NK cells gain higher IFN-γ competence during terminal differentiation.
Luetke-Eversloh M; Cicek BB; Siracusa F; Thom JT; Hamann A; Frischbutter S; Baumgrass R; Chang HD; Thiel A; Dong J; Romagnani C
Eur J Immunol; 2014 Jul; 44(7):2074-84. PubMed ID: 24752800
[TBL] [Abstract][Full Text] [Related]
38. Human NK1 and NK2 subsets determined by purification of IFN-gamma-secreting and IFN-gamma-nonsecreting NK cells.
Deniz G; Akdis M; Aktas E; Blaser K; Akdis CA
Eur J Immunol; 2002 Mar; 32(3):879-84. PubMed ID: 11870632
[TBL] [Abstract][Full Text] [Related]
39. Augmentation of NK cell activity by IL-2.
Herberman RB
Prog Clin Biol Res; 1987; 244():267-74. PubMed ID: 3498952
[No Abstract] [Full Text] [Related]
40. Differentiation of NK1 and NK2 cells.
Kimura MY; Nakayama T
Crit Rev Immunol; 2005; 25(5):361-74. PubMed ID: 16167886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
